NEWSROOM

January 31, 2023

Grifols included in Bloomberg Gender-Equality Index for the third consecutive year for its leadership in equality, diversity and inclusion

January 11, 2023

Grifols achieves positive topline results from phase 3b study of its fibrin sealant to treat surgical bleeding in pediatric patients

December 12, 2022

Grifols recognized as one of the world’s most sustainable companies by Dow Jones Sustainability Index for third consecutive year

December 5, 2022

Grifols’ national partnership with Habitat for Humanity International helps address affordable U.S. housing shortage

November 8, 2022

Grifols’ Biopharma delivers robust 34% operational growth in Q3, driving revenues to EUR 4,351m in the first nine months of 2022